Literature DB >> 31390636

Effects of Siniruangan Recipe on Proliferation, Apoptosis and Activation of Human Hepatic Stellate Cell Line LX-2.

Jinming Liu1,2, Guorong Zhao3, Bichen Ai4, Yirong He4, Ming Mei1, Junju Zou1, Biyue Xiao4, Zhouan Yin1.   

Abstract

BACKGROUND: Experimental and clinical evidence suggests that liver fibrosis is potentially reversible. Hepatic stellate cells (HSCs) play a key role in the development of hepatic fibrosis. Previous clinical applications and researches showed that Siniruangan recipe (SNRG) reversed liver fibrosis and even liver cirrhosis. This experimental study aimed to elucidate the effects of SNRG on the proliferation, apoptosis and activation of HSCs.
METHODS: The human HSCs line LX-2 was cultured with normal culture medium and multi-dose SNRG water decoction for 48 h. Cell Counting Kit-8 assay was used to detect the proliferation and cytotoxicity of LX-2 cells. Annexin V-FITC/PI double staining was performed to identify apoptotic cells. Immunofluorescence staining was used to determine the relative content of cleaved caspase-3, tissue inhibitor of metalloproteinase-1 (TIMP-1) and transforming growth factor-β1 (TGF-β1) in LX-2 cells. Western blot was used to detect the relative content of Bcl-2, Bax, α-smooth muscle actin, β-catenin and TIMP-1 protein expression in LX-2 cells.
RESULTS: The SNRG inhibited the proliferation of LX-2 and induced cell apoptosis through caspase-dependent and mitochondrial-dependent pathways. SNRG may inhibit the activation of LX-2 through the β-catenin pathway. The decrease in TIMP-1 and TGF-β1 protein induced by SNRG promoted the degradation of the extracellular matrix (ECM).
CONCLUSIONS: SNRG induced LX-2 cell apoptosis, inhibited cell proliferation, decreased LX-2 cell activity and promoted the degradation of ECM in vitro, which may be important mechanisms for reversing liver fibrosis and liver cirrhosis.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Extracellular matrix; Hepatic stellate cell; LX-2; Proliferation; Siniruangan recipe

Mesh:

Substances:

Year:  2019        PMID: 31390636     DOI: 10.1159/000500800

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  MicroRNA-15a inhibits hepatic stellate cell activation and proliferation via targeting SRY-box transcription factor 9.

Authors:  Maoying Fu; Weihua Yin; Wei Zhang; Yanfang Zhu; Huihui Ni; Li Gong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  RNF2 Mediates Hepatic Stellate Cells Activation by Regulating ERK/p38 Signaling Pathway in LX-2 Cells.

Authors:  Qi Yan; Linxin Pan; Shunli Qi; Fang Liu; Zhen Wang; Cheng Qian; Lijian Chen; Jian Du
Journal:  Front Cell Dev Biol       Date:  2021-03-18

3.  PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.

Authors:  Yu Chen; Xin Chen; Ya-Ru Ji; Sai Zhu; Fang-Tian Bu; Xiao-Sa Du; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  J Cell Mol Med       Date:  2020-05-28       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.